# The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers

> **NCT02581696** · PHASE1 · COMPLETED · sponsor: **Boryung Pharmaceutical Co., Ltd** · enrollment: 24 (actual)

## Conditions studied

- Peptic Ulcer

## Interventions

- **DRUG:** Lafutidine
- **DRUG:** Irsogladine maleate

## Key facts

- **NCT ID:** NCT02581696
- **Lead sponsor:** Boryung Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02581696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02581696, "The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02581696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*